Cargando…
Early detection of anthracycline‐ and trastuzumab‐induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters
AIMS: To evaluate echocardiographic and biomarker changes during chemotherapy, assess their ability to early detect and predict cardiotoxicity and to define the best time for their evaluation. METHODS AND RESULTS: Seventy‐two women with breast cancer (52 ± 9.8 years) treated with anthracyclines (26...
Autores principales: | Díaz‐Antón, Belén, Madurga, Rodrigo, Zorita, Blanca, Wasniewski, Samantha, Moreno‐Arciniegas, Andrea, López‐Melgar, Beatriz, Ramírez Merino, Natalia, Martín‐Asenjo, Roberto, Barrio, Patricia, Amado Escañuela, Maximiliano German, Solís, Jorge, Parra Jiménez, Francisco Javier, Ciruelos, Eva, Castellano, José María, Fernández‐Friera, Leticia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934964/ https://www.ncbi.nlm.nih.gov/pubmed/35106939 http://dx.doi.org/10.1002/ehf2.13782 |
Ejemplares similares
-
The Quest for an Early Marker of Anthracycline-Induced Cardiotoxicity
por: Ibanez, Borja, et al.
Publicado: (2022) -
Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer
por: Arciniegas Calle, Maria C., et al.
Publicado: (2018) -
Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
por: Altomare, Claudia, et al.
Publicado: (2021) -
Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020) -
Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)